Chemical Structure : NCB-0846
CAS No.: 1792999-26-8
货号: PC-42270Not For Human Use, Lab Use Only.
NCB-0846 (NCB0846) is the first orally available, small-molecule TNIK inhibitor with IC50 of 21 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | ¥3580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NCB-0846 (NCB0846) is the first orally available, small-molecule TNIK inhibitor with IC50 of 21 nM.
NCB-0846 also weakly inhibits FLT3, JAK3, PDGFRα, TRKA, CDK2/CycA2, and HGK (IC80>0.1 uM).
NCB-0846 induces faster migration of TCF4 phosphorylated by TNIK at 0.1-0.3 uM, and completely inhibits at 3 uM; also reduces the expression of TNIK, AXIN2, cMYC, LRP6 and LRP5.
NCB-0846 abrogates colorectal cancer stemness, suppresses Wnt-driven intestinal tumorigenesis in Apc(min/+) mice.
分子量 | 375.4237 | |
分子式 | C21H21N5O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 30 mg/mL |
|
Chemical Name/SMILES |
Cyclohexanol, 4-[[2-(1H-benzimidazol-6-ylamino)-8-quinazolinyl]oxy]-, cis- |
1. Masuda M, et al. Nat Commun. 2016 Aug 26;7:12586.
2. Yamada T, et al. Cancer Sci. 2017 May;108(5):818-823.
3. Mahmoudi T, et al. EMBO J. 2009 Nov 4;28(21):3329-40.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright